• / Free eNewsletters & Magazine
  • / My Account
Home>G-7

G-7

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Gloom surrounding Europe is overdone, Trichet says in interview

    Gloom surrounding Europe is overdone, Trichet says in interview

  2. Gloom surrounding Europe is overdone, Trichet -2-

    Gloom surrounding Europe is overdone, Trichet -2-

  3. Global Tourette Syndrome Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Neurocrine Biosciences, Otsuka Holdings, Pfizer - Research and Markets

    Global Tourette Syndrome Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Neurocrine Biosciences, Otsuka Holdings, Pfizer - Research and Markets

  4. Global Spinal Cord Injury Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Pfizer, Allergan, Stem Cell Sciences - Research and Markets

    Global Spinal Cord Injury Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Pfizer, Allergan, Stem Cell Sciences - Research and Markets

  5. Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: GlaxoSmithKline, Allergan, SFBC - Research and Markets

    Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: GlaxoSmithKline, Allergan, SFBC - Research and Markets

  6. Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Mallinckrodt, Y's Therapeutics, Prolong Pharma - Research and Markets

    Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Mallinckrodt, Y's Therapeutics, Prolong Pharma - Research and Markets

  7. Arterial Calcification Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Medestea Internazionale, Amgen, VitaK - Research and Markets

    Arterial Calcification Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Medestea Internazionale, Amgen, VitaK - Research and Markets

  8. Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Biogen, Sanofi, Novartis - Research and Markets

    Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Biogen, Sanofi, Novartis - Research and Markets

  9. Takeda to develop Zika Vaccine with up to $312 million in funding from US Government

    Takeda to develop Zika Vaccine with up to $312 million in funding from US Government

  10. Has Quantitative Easing Given Labor Markets a Bump?

    Last year, G7 nations that implemented aggressive QE programs saw their unemployment rates drop by more than 1%, while those that didn't saw their rates increase or stay the same.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.